Skip to content

Clinical trials

Irritable Bowel Syndrome trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Irritable Bowel Syndrome Country / region: United States Clear all

292 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20012
20021
20036
20046
20054
200611
200710
200813
200921
201020
20119
201212
20139
201415
20156
201611
201713
201813
201916
202012
202112
202212
202314
20249
202516
202615

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed194
Terminated33
Recruiting29
Unknown status12
Not yet recruiting8
Withdrawn6
Enrolling by invitation4
Suspended3
Active, not recruiting3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Mayo Clinic19
University of California, Los Angeles11
University of Michigan10
Baylor College of Medicine9
Beth Israel Deaconess Medical Center7
GlaxoSmithKline7
University of North Carolina, Chapel Hill7
Bausch Health Americas, Inc.6
Stanford University6
Massachusetts General Hospital5

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Irritable Bowel Syndrome292
Abdominal Pain40
Diarrhea30
Constipation22
Fibromyalgia17
Gastrointestinal Diseases16
Inflammatory Bowel Diseases16
Colitis, Ulcerative14
Crohn Disease14
Anxiety Disorders11

Trials

Showing 1 to 25 of 292. Each trial links to its page on Pharma Observatory.

192 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.